胺治疗可以缓解高风险人群的自杀念头:系统性审查和元分析
Wen Tang1, Wei-Wei Jiang1,2, Wen-Qian Que3,4,5
1Nursing Department, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China.
Epidemiology and psychiatric sciences
|January 12, 2026
概括
胺可显著降低高风险个体的自杀念头,特别是年轻的患者和那些症状严重的人. 需要进一步的研究来优化胺治疗和评估长期影响.
科学领域:
- 精神病学和药理学 精神病学和药理学
- 心理健康研究 心理健康研究
- 临床试验分析
背景情况:
- 自杀念头 (SI) 构成了重大的公共卫生挑战,特别是在高风险人群中.
- 现有的SI治疗方法存在局限性,需要探索新型治疗剂.
- 胺,一种N-甲基-D-酸盐受体对抗剂,已经显示出快速的抗抑郁作用.
研究的目的:
- 系统地审查和分析关于胺胺在降低高风险个体中SI功效的实验证据.
- 估计胺治疗对SI的整体效应大小.
- 识别影响氨酸有效性的潜在调节者,并报告不良事件.
主要方法:
- 按照PRISMA指南进行系统审查和元分析.
- 包括双盲随机受控试验和开放标签研究对胺的SI.
- 随机效应元分析以确定SI的标准化平均差异,并对不良事件和调节效应进行二次分析.
主要成果:
- 分析了21项涉及927名参与者的研究,显示SI显著且具有临床意义的减少 (大效果大小:-1.40).
- 常见的不良事件包括分离 (38.8%),恶心 (31.6%),头 (24.7%),头痛 (22.0%) 和焦虑 (15.8%).
- 调节者分析表明,在年轻人和患有严重SI的人群中,疗效更大.
结论:
- 胺在降低高风险人群,特别是年轻人和严重自杀念头的人群中显著有效.
- 副作用是常见的,但可以管理的,分离是常见的副作用.
- 进一步的研究对于确定最佳胺剂量和评估长期治疗结果和安全性至关重要.
更多相关视频
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
509
10:54Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
Published on: November 21, 2025
271
相关概念视频
01:30Electroconvulsive Therapy
841
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
841
01:23Antidepressant Drugs: MAOIs and Other Agents
791
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
791
01:28Drug Therapy
237
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
237
01:26Psychosis: Goals of Pharmacotherapy
457
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
457